Berberine (BBR) exerts powerful renoprotective effects on
diabetic nephropathy (DN), but the underlying mechanisms remain unclear. We previously demonstrated that activation of the
G protein-coupled
bile acid receptor TGR5 ameliorates
diabetic nephropathy by inhibiting the activation of the
sphingosine 1-phosphate (S1P)/
sphingosine 1-phosphate receptor 2 (S1P2) signaling pathway. In this study, we explored the role of TGR5 in the BBR-induced downregulation of
sphingosine 1-phosphate receptor 2 (S1P2)/
mitogen-activated protein kinase (MAPK)-mediated
fibrosis in glomerular mesangial cells (GMCs). Results showed that, BBR suppressed the expression of FN,
ICAM-1, and TGF-β1 in high-
glucose cultures of GMCs, and the phosphorylation level of c-Jun/c-Fos was downregulated. The high
glucose lowered TGR5 expression in a time-dependent manner; this effect was reversed by BBR in a dose-dependent manner. The TGR5 agonist
INT-777 decreased the high
glucose-induced FN,
ICAM-1, and TGF-β1
protein contents. In addition, TGR5
siRNA blocked S1P2 degradation by BBR. And MAPK signaling, which plays important regulatory roles in the pathological progression of DN, was activated by TGR5
siRNA. Apart from this, MAPK signaling as well as FN,
ICAM-1, and TGF-β1 suppressed by BBR under high
glucose conditions were limited by TGR5 depletion. Thus, BBR decreases FN,
ICAM-1, and TGF-β1 levels under high
glucose conditions in GMCs possibly by activating TGR5 and inhibiting S1P2/MAPK signaling.